| 000 | 01628 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514185402.0 | ||
| 264 | 0 | _c20041222 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a0340-6245 | ||
| 024 | 7 |
_a10.1160/TH03-11-0668 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAgema, Willem R P | |
| 245 | 0 | 0 |
_aPharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosis. _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cMay 2004 |
||
| 300 |
_a986-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCoronary Artery Disease _xdrug therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aDrug Resistance _xgenetics |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aLipopolysaccharide Receptors _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xphysiology |
| 650 | 0 | 4 |
_aPravastatin _xpharmacology |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Immunologic _xgenetics |
| 700 | 1 | _aWouter Jukema, J | |
| 700 | 1 | _ade Maat, Moniek P M | |
| 700 | 1 | _aZwinderman, Aeilko H | |
| 700 | 1 | _aKastelein, John J P | |
| 700 | 1 | _aRabelink, Ton J | |
| 700 | 1 | _avan der Wall, Ernst E | |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 91 _gno. 5 _gp. 986-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1160/TH03-11-0668 _zAvailable from publisher's website |
| 999 |
_c14826885 _d14826885 |
||